EUVIMEDEUVIMED entdecken
Open Access

A temperature-responsive dual-hormone foam nanoengine improves rectal absorptivity of insulin-pramlintide for diabetes treatment

Shujun Feng iD, Yu Zhang iD, Chunyuan Hou iD, Yuta Liu iD, Yanfeng Gao iD, Yujun Song iD, Jun Luo iD

Science Advances · 2024

DOI: 10.1126/sciadv.adn8695 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Shujun Feng und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Nanjing University of Science and Technology, Nanjing 210094, China. Hauptthemen laut MEDLINE: Nanoparticles, Diabetes Mellitus, Rectum, Insulin. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the therapeutic benefits of insulin-pramlintide dual-hormone therapy in diabetes, its application potential has been limited due to a lack of efficient delivery routes. Here, we developed a temperature-responsive dual-hormone foam nanoengine (HormFoam) and combined it with a customized spraying device to further construct an in situ foam-generating system for improving the rectal bioavailability of dual-hormone therapy. To support rapid clinical translation, a continuous microfluidic preparation for HormFoam was proposed, including the power unit of perfluorocarbon nanodroplets and the pharmaceutical components Pluronic F127–functionalized liposomal insulin and pramlintide. We found that HormFoam could consistently generate foams to drive drugs forward after rectal administration, which enhanced intestinal distribution and mucosa absorption, leading to systemic codelivery of insulin-pramlintide. HormFoam reproduced the physiology of endocrine pancreas for glycemic control and induced body weight loss while reversing metabolic disorders in diabetic mice with good biosafety. Therefore, HormFoam represents a state-of-the-art dual-hormone regimen with the potential to address unmet needs in diabetes management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesDiabetes MellitusRectumInsulinIslet Amyloid PolypeptideRectal AbsorptionTemperatureCaco-2 CellsHumansAnimalsMiceRatsMice, Inbred ICRRats, Sprague-DawleyDosage FormsLiposomesMucusBiocompatible Materials

Substanzen

Dosage FormsLiposomesInsulinpramlintideIslet Amyloid PolypeptideBiocompatible Materials

Autor:innen und Institutionen

  • School of Chemistry and Chemical Engineering, Nanjing University of Science and Technology, Nanjing 210094, China.
  • College of Engineering and Applied Sciences, Nanjing University, Nanjing 210023, China.
  • School of Medical Imaging, Wannan Medical College, Wuhu 241002, China.

ORCID-Profile: Shujun Feng, Yu Zhang, Chunyuan Hou, Yuta Liu, Yanfeng Gao, Yujun Song, Jun Luo

Zitieren

APA

Feng, S., Zhang, Y., Hou, C., Liu, Y., Gao, Y., Song, Y., & Luo, J. (2024). A temperature-responsive dual-hormone foam nanoengine improves rectal absorptivity of insulin-pramlintide for diabetes treatment. Science Advances. https://doi.org/10.1126/sciadv.adn8695

Vancouver

Feng S, Zhang Y, Hou C, Liu Y, Gao Y, Song Y, et al. A temperature-responsive dual-hormone foam nanoengine improves rectal absorptivity of insulin-pramlintide for diabetes treatment. Science Advances. 2024. doi:10.1126/sciadv.adn8695

BibTeX
@article{Feng2024,
  author = {Feng, Shujun and Zhang, Yu and Hou, Chunyuan and Liu, Yuta and Gao, Yanfeng and Song, Yujun and Luo, Jun},
  title = {A temperature-responsive dual-hormone foam nanoengine improves rectal absorptivity of insulin-pramlintide for diabetes treatment},
  journal = {Science Advances},
  year = {2024},
  doi = {10.1126/sciadv.adn8695}
}
Kostenlos starten →